Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Matrix Metalloproteinase-13 (MMP-13) fluorometric drug discovery kit

BML-AK413-0001 96 wells 502.00 USD
Do you need bulk/larger quantities?
A QUANTIZYME® Assay System. The MMP-13 Fluorometric (also known as fluorimetric) Drug Discovery Kit is a complete assay system designed to screen inhibitors of matrix metalloproteinase-13 (MMP-13, collagenase-3) using a quenched fluorogenic peptide: OMNIMMP® fluorogenic substrate Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH. Mca fluorescence is quenched by the Dpa group until cleavage by MMPs at the Gly-Leu bond separates the two moieties. The assays are performed in a convenient 96-well microplate format. The kit is useful to screen inhibitors of MMP-13, a potential therapeutic target. Included are active enzyme, assay buffer, a prototypic control inhibitor (NNGH3), and a detailed instruction booklet.

Product Specification

Alternative Name:Collagenase-3
Applications:Fluorescent detection, HTS
Activity assay
Shipping:Shipped on Dry Ice
Long Term Storage:-80°C
Contents:MMP-13 enzyme (human) (recombinant), substrate, calibration standard, inhibitor, assay buffer, 96-well white microplate.
UniProt ID:P45452

Product Literature References

Conditional activation of β‐catenin signaling in mice leads to severe defects in intervertebral disc tissue: M. Wang, et al.; Arthritis Rheum. 64, 2611 (2012), Application(s): Inhibition assay, Abstract; Full Text

Product Toolbox


Certificate of Analysis


By target:
By biological activity:
MMP Activity kit
MMP-13 Activity kit
By catalog section:


Technical Service
Customer Service

Related Literature

Stem Cells
Stem Cells
Download as PDF

Technical Posters
Disease-Associated Stress Signaling
Disease-Associated Stress Signaling
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2018 Enzo Life Sciences, Inc.,